Developing drugs to decrease the toxicity of chemotherapy

J Clin Oncol. 2001 Jul 15;19(14):3439-41. doi: 10.1200/JCO.2001.19.14.3439.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Breast Neoplasms / drug therapy
  • Clinical Trials as Topic
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drugs, Investigational*
  • Heart / drug effects
  • Humans
  • Liposomes
  • Razoxane / therapeutic use

Substances

  • Antineoplastic Agents
  • Drugs, Investigational
  • Liposomes
  • Razoxane
  • Doxorubicin